...Zoltán H. Endre The clinical implementation of urinary and plasma renal injury biomarkers has been hampered by the variability associated with nonstandardized commercially available biomarker assays, uncertainty and variations in patient selection criteria, and the absence of context-specific...

...Prasad Devarajan; Patrick Murray Novel biomarkers are required to improve the timely detection of early acute kidney injury (AKI) and to improve the differential diagnosis, prognostic assessment, and management of AKI cases. It is anticipated that novel biomarkers of early structural AKI (‘acute...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Tubular damage Biomarker Diabetic nephropathy Diabetes mellitus Neutrophil gelatinase-associated lipocalin Diabetic nephropathy is characterized by decreasing...

..., instructions or products referred to in the content or advertisements. Type IV collagen Basement membrane Biomarker Renal biopsy Membranous nephropathy Type IV collagen is one of the major components of the extracellular matrix (ECM) including the basement membrane and the mesangial matrix...

...Sushrut S. Waikar; Joseph V. Bonventre The identification of acute kidney injury relies on tests like blood urea nitrogen and serum creatinine that were identified and incorporated into clinical practice several decades ago. This review summarizes clinical studies of newer biomarkers that may...

... therapy and predict outcome. As an ARF biomarker, MRI with dendrimer-based contrast is a promising technique deserving further development. 10 3 2006 © 2006 S. Karger AG, Basel 2006 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may...